Although it does not promote GR dimerization and transactivation, it retains anti-inflammatory potential by repressing the NF-κB signaling pathway, without inducing the expression of skin atrophy markers, when topically applied in in vitro and in vivo mouse models [39,56]. The gene discussed is NR3C1; the disease is skin atrophy.